[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Zealand Pharma A/S (ZLDPF)

Zealand Pharma A/S (ZLDPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 3,594,897
  • Shares Outstanding, K 71,526
  • Annual Sales, $ 1,395 M
  • Annual Income, $ 977,290 K
  • EBIT $ 1,111 M
  • EBITDA $ 1,058 M
  • 60-Month Beta 0.87
  • Price/Sales 2.51
  • Price/Cash Flow 3.64
  • Price/Book 1.59
  • Price/Earnings ttm 3.63
  • Earnings Per Share ttm 13.48
  • Most Recent Earnings $-0.87 on 05/07/26
  • Next Earnings Date 08/13/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.41
  • Number of Estimates 2
  • High Estimate $-0.01
  • Low Estimate $-0.82
  • Prior Year $16.06
  • Growth Rate Est. (year over year) -102.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
45.3000 +10.95%
on 05/04/26
55.3600 -9.21%
on 05/07/26
+2.7900 (+5.88%)
since 04/22/26
3-Month
35.9310 +39.88%
on 03/06/26
57.6700 -12.85%
on 03/04/26
-10.1600 (-16.82%)
since 02/19/26
52-Week
35.9310 +39.88%
on 03/06/26
83.1200 -39.53%
on 11/20/25
-12.0800 (-19.38%)
since 05/22/25

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Zealand Pharma A/S is a biotechnology company. It focused on the discovery, design and development of peptide-based medicines. The company's pipeline includes ZP4207, single-dose rescue treatment for acute, severe hypoglycemia; ZP1848 for short bowel syndrome and ZP4207, multiple-dose version intended...

See More

Key Turning Points

3rd Resistance Point 50.2600
2nd Resistance Point 50.2600
1st Resistance Point 50.2600
Last Price 50.2600
1st Support Level 50.2600
2nd Support Level 50.2600
3rd Support Level 50.2600

See More

52-Week High 83.1200
Fibonacci 61.8% 65.0938
Fibonacci 50% 59.5255
Fibonacci 38.2% 53.9572
Last Price 50.2600
52-Week Low 35.9310

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.